CJC-1295 with DAC 10MG

Description

CJC-1295 with DAC 10 mg is a synthetic research peptide developed as a modified analog of growth hormone-releasing hormone (GHRH) for controlled laboratory and analytical investigation. The peptide incorporates a Drug Affinity Complex, commonly referred to as DAC, which is designed to facilitate covalent association with circulating proteins such as albumin in experimental systems. This structural modification makes CJC-1295 with DAC relevant to peptide research involving molecular stability, receptor pharmacology, protein binding, and peptide pharmacokinetic behavior.

Within structured laboratory peptide research, CJC-1295 with DAC 10 mg may be evaluated in experimental models examining GHRH receptor interactions, receptor-mediated signaling, peptide stability, ligand-response relationships, albumin-associated binding behavior, comparative peptide characterization, and analytical method development. Its modified molecular architecture also supports research into how peptide engineering can influence physicochemical properties, receptor interaction profiles, and experimental persistence under controlled non-clinical conditions.

NexBio supplies CJC-1295 with DAC 10 mg as part of its peptide research supply catalog with an emphasis on clear product identification, research-only designation, batch traceability, and available analytical documentation. Researchers should review the applicable product label, batch identifier, stated specifications, and Certificate of Analysis where available before incorporating this laboratory research peptide into an established experimental protocol. Any reported purity, identity, composition, or analytical specification should be verified against the documentation associated with the applicable batch.

Research Applications

CJC-1295 with DAC 10 mg may be utilized in laboratory peptide research activities including:

• GHRH receptor signaling research
• Growth hormone-releasing hormone analog characterization
• Peptide-receptor interaction studies
• Drug Affinity Complex research
• Albumin-binding peptide studies
• Peptide stability investigations
• Ligand-response characterization
• Peptide pharmacokinetic research models
• Comparative research peptide analysis
• Molecular structure-function studies
• Analytical method development
• Controlled laboratory peptide research

Research applications may vary according to experimental design, analytical methodology, laboratory protocols, institutional requirements, research model, and individual study objectives.

Storage & Handling

To help maintain research material integrity:

• Store according to the conditions stated on the product label or applicable batch documentation.
• Keep CJC-1295 with DAC 10 mg in its original labeled container until required for laboratory research.
• Protect from excessive heat, direct light, moisture, and unnecessary environmental exposure.
• Minimize repeated or unnecessary handling that could affect peptide integrity.
• Use appropriate laboratory techniques to reduce contamination risk.
• Maintain clear sample and batch identification throughout research workflows.
• Follow institutional safety procedures and product-specific documentation during storage and handling.

Quality Assurance

CJC-1295 with DAC 10 mg is supplied under quality-focused procedures designed to support peptide identification, specification consistency, batch traceability, and research transparency. Applicable analytical review may include identity assessment, purity evaluation, peptide characterization, batch verification, and supporting laboratory documentation. A Certificate of Analysis (COA) or related batch-specific analytical record may be available for the applicable lot.

Any statement regarding peptide purity, identity, DAC modification, analytical methodology, or other testing specifications should be confirmed using the corresponding batch documentation.

Additional Information

Specification	Details
Product Name	CJC-1295 with DAC 10 mg
Compound Name	CJC-1295 with DAC
Product Type	Synthetic Research Peptide
Presentation	10 mg
Peptide Classification	Modified GHRH Analog
Structural Feature	Drug Affinity Complex (DAC)
Primary Research Target	GHRH Receptor System
Research Classification	Research Use Only (RUO)
Research Category	GHRH Analog and Peptide Pharmacology Research
Research Focus	Receptor Signaling, Protein Binding, Peptide Stability, and Molecular Characterization
Related Research Entities	GHRH, GHRH Receptor, DAC, Albumin Binding, Peptide Pharmacokinetics
Research Environment	Controlled Peptide Laboratory Research
Intended Use	Laboratory Research and Analytical Testing
Documentation	Batch Analytical Documentation Where Available

Research Use Disclaimer

FOR RESEARCH USE ONLY (RUO).

CJC-1295 with DAC 10 mg is supplied exclusively for laboratory research, analytical testing, and scientific investigation purposes.

This product is not intended for human or veterinary administration, clinical use, therapeutic use, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.

This research material is not offered or represented by NexBio as a finished drug product, therapeutic treatment, dietary supplement, or consumer-use product. By purchasing this material, the buyer acknowledges that it is intended solely for appropriately controlled research environments and must be handled in accordance with applicable laboratory procedures, institutional requirements, product documentation, and laws.